College Stock: Penny Stock News

Another notable aspect of the latest botched IVF heard around the world is that the embryos could have been mixed-up because they were frozen in storage with dozens if not hundreds of other embryos.

Many women are already discouraged by the fact that doctors told them they are infertile and must seek alternative treatments such as IVF. But now, The Dean thinks this mix-up spotlights the downsides to commonly used IVF procedures.

An article from the NY Daily News reports that in the United States nearly 2 million reproductive aged women have problems with infertility. The article also discussed that there’s a high risk that IVF will result in multiple births, citing that there were 54,656 infants born through IVF procedures in 2006 and half were multiple births.

The Dean has told all of his students that this is a leading deterrent for women in seeking infertility treatments. But what most of the United States and world population do not realize is that $IVOB‘s INVO procedure reduces this risk by implanting a maximum of 2 embryos. $IVOB announced yesterday afternoon that they will be attending and presenting at a fertility conference in Columbia over the next couple of days and you can bet that $IVOB will reference recent media events when discussing their INVOcell device and INVO procedure.

The Dean thinks that such events are relevant because they could have even more of an impact on how the world views the infertility treatment market, especially when it comes to excess and frozen embryos sitting in storage.

$IVOB‘s INVO procedure does not produce excess embryos so it certainly does not require embryos to be frozen and stored. Rather, in the INVO procedure, “one or two developing embryos are transferred directly into the woman’s uterine cavity, where implantation and continued pregnancy can take place.”

The Dean believes this is another cost-effective aspect of $IVOB‘s INVO procedure because couples do not have to pay to store frozen embryos, which CBS News reports could cost as much as $2,000 a year.

$IVOB‘s INVO procedure could also be viewed as a more ethical IVF treatment because there are no left over embryos to be used for research, disposed of, or accidentally given to the wrong infertile couple. This also raises the question, “Why are so many eggs fertilized to created embryos that are not needed?” The Dean thinks the answer to that comes with the large amount of drugs used by most IVF procedures to stimulate egg production in infertile women. Those eggs are then used to create embryos in an expensive IVF process to be stored in a lab that needs a large amount of electricity, gas and equipment to simulate the natural conditions inside a woman’s body.

The Dean believes that $IVOB‘s technology has truly outmatched conventional IVF methods and, given FDA approval in the United States, could become the standard alternative reproductive therapy used by millions of couples.

Want to learn MORE and MAXIMIZE your earning potential and learn about The Dean’s Ivy League Stock Picks before the rest of the CollegeStock Community by signing up for Honors Class. 230 Honors Students can’t be wrong!

October 1st is coming soon so make sure you’re eligible to become the first winner of The Dean’s Scholarship Fund!